Company Overview
Amarantus BioScience Holdings, Inc. is a publicly traded biotechnology company focused on developing therapeutic products with the potential for orphan drug designation in the areas of neurology, psychiatry, ophthalmology and regenerative medicine, and diagnostics in neurology.
Recent News
Amarantus Announces Subsidiary MANF Therapeutics Enters Into Material Transfer Agreement with Dyadic International
Amarantus Releases Letter to Shareholders
Amarantus Acquires Majority Interest in CBD Wellness Company Hempori
Stock Overview
Symbol
AMBS
Exchange
OTCPink
Shares OS
68,272,000
Market Cap
$1.24M
Last Price
$0.0181
52-Week Range
$0.01 - $0.039625
Fiscal Year End
December 31
Last Trade Time
02/21/2020 03:31 PM EST
Investor Relations
American Capital Ventures, Inc.
Howard Gostfrand
President
T: 305-918-7000
F: 305-468-6165
hg@amcapventures.com